Medicare Enrolled

Dr. Jonathan Arbogast, MD

Family Medicine · Clio, MI
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
4154 W VIENNA RD, Clio, MI 48420
8106871008
In practice since 2006 (19 years)
NPI: 1326140906 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Arbogast from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Arbogast? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Arbogast

Dr. Jonathan Arbogast is a family medicine specialist in Clio, MI, with 19 years of NPI registration. Based on federal Medicare data, Dr. Arbogast performed 765 Medicare services across 568 unique beneficiaries.

Between the years covered by Open Payments, Dr. Arbogast received a total of $7,031 from 54 pharmaceutical and/or device companies across 488 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Arbogast is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 22% volume in MI $7,031 industry payments

Medicare Practice Summary

Medicare Utilization ↗
765
Medicare services
Top 22% in MI for family medicine
568
Unique beneficiaries
$29
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~40 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
212 $41 $197
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
198 $8 $17
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
116 $41 $229
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
70 $39 $134
Urinalysis, manual
A manual laboratory examination of a urine sample to check for various substances and cells.
44 $3 $9
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
37 $29 $40
Flu vaccine, high-dose
High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe.
31 $71 $82
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
31 $9 $40
Blood glucose test using hand-held instrument
A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels.
13 $3 $10
Transitional care management services, moderate complexity
Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity.
13 $65 $426
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,031
Total received (2018-2024)
Avg $1,004/year across 7 years
Top 5% in MI for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
488
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,989 (99.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$43 (0.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$992
2023
$387
2022
$588
2021
$1,142
2020
$1,231
2019
$1,079
2018
$1,612

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$214
ABBVIE INC.
$180
Xeris Pharmaceuticals, Inc.
$109
AstraZeneca Pharmaceuticals LP
$106
Astellas Pharma US Inc
$62
Exact Sciences Corporation
$60
Bayer Healthcare Pharmaceuticals Inc.
$56
Lundbeck LLC
$46
Novo Nordisk Inc
$31
Abbott Laboratories
$23
Otsuka America Pharmaceutical, Inc.
$22
Axsome Therapeutics, Inc.
$17
Lilly USA, LLC
$17
Phathom Pharmaceuticals, Inc.
$17
Merck Sharp & Dohme LLC
$16
Lexicon Pharmaceuticals, Inc.
$15
Top 3 companies account for 50.7% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$708
PFIZER INC.
$691
GlaxoSmithKline, LLC.
$523
Janssen Pharmaceuticals, Inc
$459
AstraZeneca Pharmaceuticals LP
$446
SANOFI-AVENTIS U.S. LLC
$424
Lilly USA, LLC
$331
Astellas Pharma US Inc
$309
Boehringer Ingelheim Pharmaceuticals, Inc.
$308
Biohaven Pharmaceuticals, Inc.
$266
AbbVie Inc.
$214
ABBVIE INC.
$213
Novartis Pharmaceuticals Corporation
$212
Xeris Pharmaceuticals, Inc.
$166
Merck Sharp & Dohme Corporation
$149
Takeda Pharmaceuticals U.S.A., Inc.
$148
Sunovion Pharmaceuticals Inc.
$105
Allergan, Inc.
$92
Amarin Pharma Inc.
$91
Teva Pharmaceuticals USA, Inc.
$89
Kowa Pharmaceuticals America, Inc.
$83
Bayer Healthcare Pharmaceuticals Inc.
$82
Bayer HealthCare Pharmaceuticals Inc.
$73
Exact Sciences Corporation
$60
Nestle HealthCare Nutrition Inc.
$56
Amgen Inc.
$50
Lundbeck LLC
$46
Esperion Therapeutics, Inc.
$45
Allergan Inc.
$43
Purdue Pharma L.P.
$40
IRONWOOD PHARMACEUTICALS, INC
$36
IBSA Pharma Inc.
$36
Axsome Therapeutics, Inc.
$34
AbbVie, Inc.
$33
Alexion Pharmaceuticals, Inc.
$33
Circassia Pharmaceuticals Inc
$33
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$31
Alkermes, Inc.
$23
Abbott Laboratories
$23
Mylan Specialty L.P.
$23
Otsuka America Pharmaceutical, Inc.
$22
GENZYME CORPORATION
$17
Phathom Pharmaceuticals, Inc.
$17
Merck Sharp & Dohme LLC
$16
SANOFI PASTEUR INC.
$16
Horizon Pharma plc
$16
Vertical Pharmaceuticals, LLC
$16
Lexicon Pharmaceuticals, Inc.
$15
Sanofi Pasteur Inc.
$12
Paratek Pharmaceuticals, Inc.
$12
Daiichi Sankyo Inc.
$12
Shire North American Group Inc
$12
Dexcom, Inc.
$11
Ironwood Pharmaceuticals, Inc
$11
Top 3 companies account for 27.3% of all-time payments
Associated products mentioned in payments ›
ADACEL · AIRSUPRA · AJOVY · APTIOM · AREXVY · Aimovig · Amitiza · Auvelity · BASAGLAR · BREZTRI · BREZTRI AEROSPHERE · CHANTIX · COLOGUARD · Cologuard Collection Kit · DEXCOM CGM · DUZALLO · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · FARXIGA · FREESTYLE LIBRE 3 · GARDASIL · GVOKE HYPOPEN · GVOKE PFS · INVOKANA · JANUVIA · JARDIANCE · KRYSTEXXA · Kerendia · LINZESS · LONHALA MAGNAIR · LYRICA · Linzess · Livalo · MOUNJARO · MYRBETRIQ · Morphabond ER · NEXLETOL · NURTEC ODT · NUZYRA · Ozempic · PENTACEL · PNEUMOVAX 23 · PREMARIN · QULIPTA · RELEXXII · REXULTI · ROTATEQ · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · SYMPROIC · SYNTHROID · Saxenda · Seglentis · Strensiq · Synthroid · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TUDORZA PRESSAIR · Tirosint · Tresiba · Trintellix · UBRELVY · UTIBRON · VESICARE · VOQUEZNA · VRAYLAR · VYVANSE · Vascepa · Veozah · Victoza · Vivitrol · Wegovy · XARELTO · XIFAXAN · Yupelri · ZENPEP
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 5% for family medicine in MI.

Looking for a family medicine specialist in Clio?
Compare family medicine physicians in the Clio area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
387
Per 100K population
95.8
County median income
$60,673
Nearest hospital
HURLEY MEDICAL CENTER
12.5 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Arbogast is a clinical cardiology specialist, with above-average Medicare volume (top 22% in MI), with low-engagement industry engagement in the top 5% of MI peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Arbogast experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Arbogast performed 212 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Arbogast receive payments from pharmaceutical companies?
Yes. Dr. Arbogast received a total of $7,031 from 54 companies across 488 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Arbogast's costs compare to other family medicine physicians in Clio?
Dr. Arbogast's average Medicare payment per service is $29. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Arbogast) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →